Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-18

FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for granisetron hydrochloride from Mylan Institutional LLC, enabling its continued marketing as a generic antiemetic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron hydrochloride (granisetron hydrochloride)

Snippet

SUPPL AP for GRANISETRON HYDROCHLORIDE (GRANISETRON HYDROCHLORIDE)